Assisted Reproductive Technology
Also known as: ART, IVF, In Vitro Fertilization
Methodology & AI Transparency ⓘ
Assisted Reproductive Technology Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Assisted reproductive technology (ART) is used to treat infertility .
- 2 Real-world patient consensus: Clinical coding for Assisted Reproductive Technology uses ICD-10 O24.3 across Fertility & Pregnancy specialty care.
- 3 Typical cash cost range: Differential triage of Assisted Reproductive Technology (O24.3) utilizes gestational glycemic [Assisted Reproductive Technology O24.3].
- 4 Top reported side effects / signs: Objective lab/clinical target for Assisted Reproductive Technology: Maternal Blood Pressure in Assisted Reproductive Technology (O24.3: & Urine Protein) (BP < 120/80 mmHg; negative proteinuria (O24.3)) and Prenatal TSH, Ferritin in Assisted Reproductive Technology (O24.3: & Glucose Screen).
Ask our AI Specialists anything about Assisted Reproductive Technology
What Is Assisted Reproductive Technology?
Assisted reproductive technology (ART) is used to treat infertility . It includes fertility treatments that handle both eggs and sperm. It works by removing eggs from the ovaries. The eggs are then mixed with sperm to make embryos. The embryos are then put back in the parent's body. In vitro fertilization (IVF) is the most common and effective type of ART. ART procedures sometimes use donor eggs, donor sperm, or previously frozen embryos. It may also involve a surrogate or gestational carrier. A surrogate becomes pregnant with sperm from one partner of the couple. A gestational carrier becomes pregnant with an egg from one partner and sperm from the other partner.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Assisted Reproductive Technology (ICD-10 O24.3) is driven by gestational human placental in Assisted Reproductive Technology (O24.3: lactogen insulin resistance); Cross-referenced with NIH MeSH (Reproductive Techniques, Assisted, In Vitro Techniques), specialists in Fertility, Pregnancy & Postpartum Care monitor Prenatal TSH, Ferritin in Assisted Reproductive Technology (O24.3: & Glucose Screen) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Assisted Reproductive Technology (O24.3): gestational fasting or in Assisted Reproductive Technology (O24.3: post-load blood glucose)
- • Secondary Assisted Reproductive Technology clinical sign: inability to achieve in Assisted Reproductive Technology (O24.3: clinical pregnancy after)
- • Symptom flares in Assisted Reproductive Technology correlating with Maternal Blood Pressure in Assisted Reproductive Technology (O24.3: & Urine Protein) deviation outside BP < 120/80 mmHg; negative proteinuria (O24.3)
- • Functional fertility & pregnancy impact requiring gestational glycemic [Assisted Reproductive Technology O24.3] evaluation (O24.3)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Assisted Reproductive Technology Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | O24.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Fertility, Pregnancy & Postpartum Care | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Maternal Blood Pressure in Assisted Reproductive Technology (O24.3: & Urine Protein) | BP < 120/80 mmHg; negative proteinuria (O24.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Prenatal TSH, Ferritin in Assisted Reproductive Technology (O24.3: & Glucose Screen) | Trimester-specific clinical range (O24.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Anti-Mullerian Hormone (AMH) in Assisted Reproductive Technology (O24.3: & Day-3 FSH) | Age-contextual ovarian reserve (O24.3) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Assisted Reproductive Technology
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Relieved Pro Wrap (4% Lidocaine Patch) Relieved Pro Wrap • RxCUI 1737778-B71662004 | Amide Local Anesthetic | 94% | $0.3400 | $ 32.98 /mo |
| Etonogestrel and Ethinyl Estradiol Vaginal Enilloring • RxCUI 1367436 | Estrogen | 75% | $45.0723 | $ 185.00 /mo |
| Levonorgestrel/Ethinyl Estradiol Twirla, Jolessa • RxCUI 2396242 | Progestin | 85% | $66.7058 | $ 6.73 /mo |
| Vorvita Nail Hardener (Panthenol,hyaluronic Acid) Vorvita Nail Hardener • RxCUI RXN-B87690001 | Over-the-Counter Clinical Monograph | 85% | $2.0700 | $ 157.54 /mo |
| Yves Conopeptide Luxury Tighten Creme Eye Mask (Caffeine 0.5% Mu-Conotoxin Cniiic 0.0001% Elastin 0.009% Ubiquinone 0.02%) Yves Conopeptide Luxury Tighten Creme Eye Mask • RxCUI RXN-B85779002 | Central Nervous System Stimulant | 78% | $0.0877 | $ 14.82 /mo |
| Nerante Fungus Nail Pen (Undecylenic Acid) Nerante Fungus Nail Pen • RxCUI 998329 | Azole Antifungal | 90% | $1.8300 | $ 140.26 /mo |
| Eluryng (Etonogestrel and Ethinyl Estradiol) Eluryng • RxCUI 2266506 | Progestin | 88% | $45.0723 | $ 640.00 /mo |
| Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol Simpesse, Lo Simpesse • RxCUI 238019 | FDA Prescription Therapeutic Agent | 77% | $0.1125 | $ 13.06 /mo |
| Vienva (Levonorgestrel and Ethinyl Estradiol) Vienva • RxCUI 242297 | Progestin | 86% | $0.1509 | $ 6.73 /mo |
| Copper Paragard T 380a, Cuprum Metallicum • RxCUI 2267305 | Copper-containing Intrauterine Device | 90% | $0.8800 | $ 44.14 /mo |
| Trstay (Retinol Serum) Trstay • RxCUI RXN-B87492001 | Over-the-Counter Clinical Monograph | 82% | $1.8100 | $ 138.82 /mo |
| Hair Serum (Minoxidil 5%) Hair Serum • RxCUI 311724-B83804003 | Arteriolar Vasodilator | 74% | $0.1971 | $ 22.69 /mo |
| Endometrin (Progesterone) Endometrin • RxCUI 725094 | Progesterone | 92% | $14.0717 | $ 640.00 /mo |
| Norgestrel and Ethinyl Estradiol Cryselle, Elinest • RxCUI 311359 | FDA Prescription Therapeutic Agent | 84% | $0.2841 | $ 20.00 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Assisted Reproductive Technology)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on RCGP does U turn on policy that put assisted dying on par with arms An “ethical policy” that prevented assisted dying campaign groups from hosting events at the Royal College of General Practitioners will be “reviewed and amended,” the college pledged today.This reversal comes after the campaign group Dignity in Dying was prev BMJ Recent Research • 2026-10-29 • Peer-Reviewed Journal (Clinical Trials) | Multi-cohort | 94/100 | PMID BMJ-2116810576 ↗ |
| New Insights on Quality comparison of mediastinal lymph node dissection between video-assisted: What a 1,685-Participant Study Found This study found no significant differences in N2 upstaging proportions between the VATS and open. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery • 2025-07-01 • Phase III Randomized Trial | N = 1,685 | 90/100 | PMID 40578313 ↗ |
| New Insights on Comparison of real-world benefits and safety evaluation of vacuum-assisted Elite: What a 1,470-Participant Study Found In general, the 10-G VAB procedure is a reasonable alternative to the 14-G CNB procedure with higher accuracy. International journal of surgery (London, England) • 2023-05-01 • Phase III Randomized Trial | N = 1,470 | 90/100 | PMID 37042316 ↗ |
| Can This Approach Help? Inside the Latest Research on Self-compassion mediates treatment effects in MDMA-assisted therapy for Conclusions: These findings suggest that self-compassion may play a critical role in the therapeutic effects of MDMA-AT. European journal of psychotraumatology • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40331914 ↗ |
| Can This Approach Help? Inside the Latest Research on MDMA-assisted therapy for PTSD on Compared with Therapy with placebo, MDMA-assisted therapy had significant positive effects on transdiagnostic mental processes of self-experience which are often associated with poor treatment outcome. PloS one • 2024-01-15 • Phase III Randomized Trial | N = 46 | 88/100 | PMID 38198456 ↗ |
Assisted Reproductive Technology Patient Community & “People Like Me” Threads
Filter Assisted Reproductive Technology community threads and patient logs by age, biological sex, dosage, and treatment duration.